5. Y. Liu, X. Wang, C. Y. Sun, J. Wang*, Delivery of Mitogen-Activated Protein Kinase Inhibitor for Hepatocellular Carcinoma Stem Cell Therapy, ACS Applied Materials & Interfaces, 2015, 7, 1012-1020

4. S. Y. Li, R. Sun, H. X. Wang, S. Shen, Y. Liu, X. J. Du, Y. H. Zhu, J. Wang*, Combination Therapy with Epigenetic-Targeted and Chemotherapeutic Drugs Delivered by Nanoparticles to Enhance the Chemotherapy Response and Overcome Resistance by Breast Cancer Stem Cells, Journal of Controlled Release, accepted

3. R. Sun#, Y. Liu#, S.Y. Li, S. Shen, X. J. Du, C. F. Xu,Z. T. Cao, Y. Bao, Y. H. Zhu, Y. P. Li, X. Z. Yang, J. Wang*, Co-Delivery of All-trans-Retinoic Acid andDoxorubicin for Cancer Therapy withSynergistic Inhibition of Cancer Stem Cells, Biomaterials, 2015, 37, 405-414

2.T.M. Sun, Y.C. Wang, F.Wang, J.Z. Du, C.Q. Mao, C.Y. Sun, R. Z. Tang, Y. Liu, J. Zhu, Y. H. Zhu, X.Z. Yang, J. Wang*, Cancer Stem Cell Therapy Using Doxorubicin Conjugated to Gold Nanoparticles via Hydrazone Bonds, Biomaterials, 2014, 35, 836-845 (Top 25 Hottest Articles of Biomaterials, October to December 2013)

1. J.Z. Du, X.J. Du, C.Q. Mao, J. Wang*, Tailor-Made Dual pH-Sensitive Polymer-Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery, Journal of the American Chemical Society, 2011, 133, 17560-17563